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Abstract
In fetal hematopoietic organs, the switch from hematopoiesis is hypothesized to be a critical time point for organogenesis,
but it is not yet evidenced. The transient coexistence of hematopoiesis will be useful to understand the development of
fetal liver (FL) around this time and its relationship to hematopoiesis. Here, the temporal and the comparative
transcriptomic and proteomic profiles were observed during the critical time points corresponding to the initiation (E11.5),
peak (E14.5), recession (E15.5), and disappearance (3 ddp) of mouse FL hematopoiesis. We found that E11.5-E14.5
corresponds to a FL hematopoietic expansion phase with distinct molecular features, including the expression of new
transcription factors, many of which are novel KRAB (Kruppel-associated box)-containing zinc finger proteins. This time
period is also characterized by extensive depression of some liver functions, especially catabolism/utilization, immune and
defense, classical complement cascades, and intrinsic blood coagulation. Instead, the other liver functions increased, such as
xenobiotic and sterol metabolism, synthesis of carbohydrate and glycan, the alternate and lectin complement cascades and
extrinsic blood coagulation, and etc. Strikingly, all of the liver functions were significantly increased at E14.5-E15.5 and
thereafter, and the depression of the key pathways attributes to build the hematopoietic microenvironment. These findings
signal hematopoiesis emigration is the key to open the door of liver maturation.
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Introduction
During the embryonic development of many species, hemato-
poiesis shifts among multiple anatomical sites, including the aorta-
gonadmesonephros region (AGM), yolk sac (YS), placenta, fetal
liver (FL), and bone marrow (BM). The shift in hematopoiesis from
one location to another is attributable to changes in the local
hematopoietic microenvironment that are initiated by embryonic
organogenesis[1]. The switch in hematopoietic organs is thought
to be a critical time point in embryogenesis and organogenesis,
however, there are little evidences. FL is generally used as a model
for developmental hematopoiesis[2]. The transient coexistence of
hematopoiesis is useful to study the liver development. At such a
hematopoiesis-prevailing stage and thereafter, the characteristics
of liver development, particularly, a global view at the relationship
between hematopoiesis and liver development, is little known.
Liver development in mice occurs in two main stages, with each
having distinct biological properties and being separated by the
time at which hematopoietic stem cells (HSCs) from the YS or
AGM settle into the liver bud at around embryonic day 11
(E11)[3]. The first stage starts at around E8–9. During this time,
the hepatic lineage arises from foregut endoderm in response to
cardiac signals, and the liver bud is formed. The second stage
probably begins at around E11. During this stage, the number of
fetal liver HSCs (FL-HSCs) dramatically increases from 3 to 66 up
to E12 and doubles daily from E12.5 to E14.5. This number then
decreases beginning at E15.5[4–5], with HSCs finally fading away
at 2–4 day postpartum (dpp)[6]. FL-HSCs are considered to
subsequently seed the BM. In the second stage, hepatoblasts
differentiate into hepatocytes and bile-duct epithelial cells, an
event indicating the switch of the liver from a predominantly
hematopoietic organ to a metabolic one. However, the molecular
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7641mechanisms underlying liver development both during and after
hematopoiesis remain largely unknown.
The functional features of hematopoiesis and phenotype of the
hematopoietic microenvironment are distinct in the FL compared
to the BM or YS[7]. FL-HSCs have a much higher proliferative
capacity for long-term repopulation than HSCs from BM or
umbilical cord blood and acquire adult characteristics in mouse
BM between 1 and 2 weeks after birth[8–9]. Co-culture of YS
HSCs with FL nonhematopoietic cells has been shown to impart a
long-term repopulating capacity to YS HSCs engrafting the
BM[10]. Thus, the FL microenvironment not only stimulates
expansion of the hematopoietic system, but also may modify the
characteristics of HSCs. The FL stroma also behaves much more
efficiently than the BM stroma to support hematopoiesis or
differentiation of embryonic stem cells (ESCs) into hematopoietic
cells[11]. However, the exact mechanisms that endow the FL
microenvironment and FL-HSCs such specificities remain elusive.
Here, we used transcriptomic and proteomic approaches to
analyze global changes in FLhematopoiesis inmurine liver at E11.5,
E14.5, E15.5, and 3 dpp. Our data not only profile the features and
orchestration of transitional hematopoiesis and hepatogenesis, but
also reveal that hematopoiesis emigration gates liver maturation.
Materials and Methods
Mouse strains
C57BL/6J mouse strains were bred and maintained at the
National Institute of Biological Sciences (NIBS), Beijing. Age-
matched embryos were generated by timed mating; the day of
vaginal plug detection was considered to be E0.5. All animal
experiments in this study were approved by the Institutional
Animal Care and Use Committee (IACUC) of NIBS.
Liver tissue collection
Twelve liver samples were collected from each of the five mice
sacrificed at E11.5, E14.5, E15.5, and 3 ddp. Pregnant mice were
killed by either cervical dislocation or decapitation. The uterus was
removed and washed to remove maternal blood. Fetuses were
dissected under a dissection microscope (SMZ1500; Nikon, Tokyo,
Japan). The abdominal cavity was opened, and the liver under the
septum transversum was removed, taking care to avoid removal of
any adjacent tissues. The liver was shaken in ice-cold Hank’s
buffered saline solution (HBSS) to remove blood. A portion of the
liver tissue was stored in RNAlater (Ambion, Austin, TX) for RNA
extraction, while the remaining portion was directly frozen in
liquid nitrogen and stored at 280uC for protein analyses.
Microarray analysis
Liver RNA was prepared in triplicate using the RNeasy Mini kit
(Qiagen, Valencia, CA). Poly(A)+ mRNA was purified from total
RNA using the Oligotex Direct mRNA Midi/Maxi kit (Qiagen,
Valencia, CA). The integrity of each RNA sample was assessed
using an Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA).
Double-stranded complementary DNA (cDNA) and labeled
complementary RNA (cRNA) were synthesized from total RNA
and hybridized, in replicate, to Affymetrix mouse 430 2.0 gene
chips (Affymetrix, Santa Clara, CA). The chips were then
processed and scanned with the GeneChip Scanner 3000. The
resulting data were checked using GeneChip Operating Software
(GCOS) v1.1.1 (Affymetrix).
Differential in-gel fluorescence electrophoresis (2D-DIGE)
Liver tissue lysates obtained from animals at each time point
(E11.5, E14.5, E15.5, and 3 ddp) were separated using 2-D DIGE
as detailed elsewhere (Supplemental materials S1, Table S5)[12].
The resulting DIGE images were analyzed using DeCyder v.5.02
software (GE Healthcare) according to the instructions provided in
the Ettan DIGE User Manual. Images of each gel were grouped
into ‘standard’, ‘E11.5’, ‘E14.5’, ‘E15.5’, ‘3 dpp’. A one-way
ANOVA was then used to compare each time point. Statistically
significant spots (P,0.05) with an average volume ratio exceeding
2-fold were accepted for further identification.
Protein identification with mass spectrometry (MALDI-
TOF/TOF)
Protein spots of interest, as defined by the 2-D DIGE/DeCyder
analysis, were excised from cCBB-stained gels for in-gel tryptic
digestion and identified by MALDI-TOF-MS/MS as described
previously[12]. The MS and MS/MS spectra were searched
against the International Protein Index (IPI) mouse database
version 3.18 (http://www.ebi.ac.uk/IP/IPIhelp.html) using GPS
Explorer
TM Version 3.0 and MASCOT 2.0[12]. All the proteins
identified had protein scores greater than 59 (P,0.05) and
individual ions scores greater than 21 (P,0.05). All the MS/MS
spectra were further validated manually.
Data analysis
Supervised hierarchical clustering of expression data was
performed with the Cluster program 3.0 using Pearson correlation
as similarity metric and centroid linkage clustering [13]. Clustering
was visualized using the TreeView program[13]. Tissue expression
profiles were generated using GeneAtlas, a gene expression
database (http://symatlas.gnf.org/SymAtlas/) that contains gene
expression patterns on a genome scale, as determined by tissue
expression microarray on 79 human and 61 mouse tissues[14].
Functional annotation of genes and proteins was performed with
the Protein ANalysis Through Evolutionary Relationships (PAN-
THER) program (http://www.pantherdb.org), which is based on
Gene Ontology (www.geneontology.org/). Pathway analysis was
performed using Ingenuity Pathway Analysis (IPA) (www.ingenu-
ity.com), which is a robust analysis system and database (Ingenuity
Pathways Knowledge Base, IPKB) that can be used to identify
biological networks based on information extracted from peer-
reviewed literature[15].
Western blot analysis
Samples were separated on SDS-polyacrylamide gels and
transferred onto nitrocellulose membranes in a trans-blot electro-
phoresis transfer cell (Bio-Rad, Hercules, CA). Membranes were
blocked with 5% skim milk for 1 h, incubated with primary
antibody (antibodies listed in supplemental materials S1) at room
temperature for 2 h, and then incubation with horseradish
peroxidase-conjugated secondary antibody for 1 h at room
temperature. The immunoreactive proteins were visualized with
ECL reagents. All the membranes were exposed on the same X-
ray film. A semi-quantitative analysis based on optical density was
performed using QuantitiOne software (Bio-Rad, Hercules, CA).
Semi-quantitative RT-PCR
Total RNA was harvested from mouse liver samples as
described for microarray RNA isolation. Reverse transcription
(RT) was performed with M-MLV RTase (Promega, WI, USA)
and oligo dT(18). A fraction (1/25th) of the resulting RT product
was subjected to 30 cycles of standard PCR, with each cycle
consisting of 94uC for 30 s, annealing for 30 s, and 72uC for 30 s.
Other conditions are provided in Table S6.
A Switch to Liver Maturation
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Dynamic maps of mRNA and protein expression during
liver development
To gain a better understanding the biological events occurring
in the hematopoietic liver, we examined the liver transcriptomes
and proteomes at four time points that correspond to the initiation
(E11.5), peak (E14.5), recession (E15.5), and disappearance (3 dpp)
of FL hematopoiesis[4,6]. Quantitative proteomics was performed
using 2-D DIGE. Differentially expressed protein spots, with
abundance changes that were significant (P,0.05) and exceeded
2.0-fold, were filtered by performing comparisons between the
livers at every two developmental stages (Figure S1; Table S1).
The resulting protein spots were identified with MALDI-TOF/
TOF. We successfully characterized proteins from 328 spots,
representing 187 unique proteins (Table S2, S3). At the same time,
expression arrays (Affymetrix mouse 420 2.0) identified 10,374
genes (partially shown in Table S4) expressed in the same liver
samples mentioned above. A comparison of proteomic and
transcriptomic data is shown in supplemental materials S1 and
Figure S5.
The FL genes could be clustered into four main types based on
their distinct temporal expression profiles (types A–D, Figure 1A).
Type A peaked at E14.5 and then faded from E15.5 to 3 dpp.
Figure 1. Development-associated changes in tissue expression patterns and the biological functions of the four dynamic types of
liver genes. (A) The four dynamic types of liver genes with differentially expressed mRNA during E11.5, E14.5, E15.5, and 3 dpp. All the 1,428
differentially expressed genes exhibited mRNA changes between any two developmental stages that exceeded 2 fold. (B) Hierarchical clustering of
biological functions for the four dynamic types. The biological functions are annotated by PANTHER. The ratio of each function in a type is expressed
relative to its median ratio across all the four types and is depicted according to a color scale shown at the bottom. Red and green indicate the ratio
of each function above and below the median, respectively. The magnitude of deviation from the median is represented by the color saturation. (C)
Tissue expression patterns of the four dynamic types, shown for both the transcriptome and proteome. The three axes represent the ratio of the
tissue-enriched genes in liver, hematopoietic tissue, and embryonic tissue. Gene tissue distribution information was annotated by GeneAtlas.
doi:10.1371/journal.pone.0007641.g001
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shown in supplemental materials S1). Type C was globally down-
regulated around E14.5 and up-regulated thereafter. Type D
progressively increased from E11.5 to 3 dpp. Functional clustering
revealed that each of these four types of genes had different
functional profiles (Figure 1B), which are described in the
following section.
Tissue expression patterns. GeneAtlas analysis of both the
transcriptome and proteome revealed that type A was dominated
by hematopoietic tissue-enriched genes (48% of type A genes), type
B with embryonic tissue-enriched genes (39% of type B genes), and
type C and D with liver-enriched genes (51% and 61% of type C
and D genes, respectively). In addition, type C and D genes
extensively overlapped, implying that they may share similar
biological functions (Figure 1C).
FL hematopoiesis— type A genes. Of the type A genes
related to nucleoside, nucleotide, and nucleic acid metabolism,
60% were involved in mRNA transcription. In contrast, only 31%
of type B genes had this function. Notably, 46% of the type A
transcription factors were enriched in hematopoietic tissues; and
24% of those transcription factors enriched within hematopoietic
tissues did not have a functional annotation. Approximately 50%
of the type A transcription factors were KRAB box-containing
zinc finger proteins (KRAB-ZNFs). KRAB-ZNFs were over two
times more abundant in the type A group than in the type B
group, though the total number of type B genes was double the
number of type A genes. The type A group contained not only
transcription factors, but also gene products involved in neuronal
communication, such as adrenergic receptor b2 and opioid
receptor k1 (Figure 1B). Both receptors are known to affect BM
hematopoiesis[16]. At the proteome level, the type A group was
also abundant in functional groups involved in nucleoside,
nucleotide, and nucleic acid metabolism as well as cell cycle,
signal transduction, and protein metabolism and modification
(Figure S2).
Type A genes were further matched to the Stem Cell Database
(http://stemcell.princeton.edu)[17] to reveal any specificity to the
characteristic properties of FL hematopoiesis. We found that type
A genes had biological functions that were similar to those of FL-
HSC-specific genes, but not those of LT-HSC-adult (BM)-specific
genes (Figure S3). Shared functions included transcription, protein
modification and metabolism, signal transduction, cell cycle, and
development. As with type A transcription factors, which were
predominantly (one-half) KRAB-ZNFs, one-half of FL-HSC-
specific transcription factors were KRAB-ZNFs, and one-third of
LT-HSCs transcription factors were KRAB-ZNFs.
Pathway analysis identified several distinct pathways that may
participate in hematopoiesis. Combining transcriptomic and
proteomic data generated an interaction network with specialized
functions in hematopoiesis, cell cycle, cellular proliferation, gene
expression, apoptosis, and protein metabolism (especially proteol-
ysis) (Figure 2A). Factors known to be important for regulation of
hematopoiesis as well as the commitment and self-renewal of
HSCs formed the ‘‘central nodes.’’ These included CREBBP,
RUNX1, NPM1, 14-3-3E, SMARCA5, BCL2L1, CREB,
KITLG, and EZH2 (Figure 2A)[18–22]. However, proteolysis
functions were not restricted to the type A group, as different
components of the protein-ubiquitination pathway were repre-
sented in both type A and B (Table S4; Figure S4). Furthermore, 5
of the 11 type A ubiquitination-related molecules (PSMC6,
USP14, UBE1L2, UBE2V2, and UBE2O) also appeared at the
hematopoiesis peak in human FL (embryonic week 22, E22w), as
we have previously shown by proteomic profiling[23]. As type B
genes centered on embryonic development (supplemental materi-
als S1), distinct protein-ubiquitination pathways may be operative
during FL-hematopoiesis.
Developmental patterns of liver gene expression during
hematopoietic expansion— type C and D genes. Type C
and D genes were primarily involved in liver-associated functions
such as metabolism of lipids, fatty acids, steroids, carbohydrates,
and amino acids. They were also involved in immunity and
defense, cell structure and motility, signal transduction, transport,
and homeostasis. Type C and D genes showed subtly different
expression patterns. The former decreased during the expansion
phase of FL hematopoiesis (from E11.5 to E14.5), while the latter
increased continuously.
Figure 2. Pathway analysis of the dynamic types. (A) Type A network, developed by Ingenuity Pathway Analysis (www.ingenuity.com),
integrating the transcriptome (green) and proteome (red). When a gene is shared by both transcriptome and proteome, we choose its data of
proteome. The biological functions of the network are indicated with rectangles and ellipses. (B) Type C (green) and type D (red) pathways of blood
coagulation and complement cascades. Pathways shared by both types are shown as half red and green (A symbol in the pathways represents a
group of genes but not only one gene. Different Type C or D gene presents at the same symbol.).
doi:10.1371/journal.pone.0007641.g002
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plasma membrane, and nuclear proteins involved in lipid and
fatty acid metabolism, signal transduction, cell motility, and
transport. This group also included genes involved in immunity
and defense as well as macrophage- and NK cell-mediated
immunity. Signal transduction genes made up 20% of type C
genes and spanned over 55 pathways, including cell surface
receptor-mediated signal transduction pathways and cell adhesion-
mediated signaling pathways. Type D contained a high number of
proteins involved in steroid metabolism. Half of type D genes
resided at the extracellular space and plasma membrane.
The individual nature of type C and D genes was also apparent
from analysis of networks. Type C genes were mainly involved in
multiple aspects of carbohydrate metabolism, particularly carbohy-
drate utilization and catabolism. Functions of these genes included
carbohydrate degradation, binding, conversion, and transport. On
the other hand, type D genes were primarily involved in the
production of carbohydrates or glycans, with the latter category
making up40%ofcarbohydratemetabolismgenesofthistype.Type
C was unique in that it contained factors involved in energy
production (APOM, ECH1, ENPP1, GBE1, CDO1, DHRS4,
GRHPR, NNT, and PDIA5). Type C was also represented by gene
products involved in the degradation of valine, leucine, and
isoleucine as well as in acyl-CoA metabolism, fatty acid beta-
oxidation, and metabolism of ketone bodies (SAT, PTGS1,
ACOX1, HMGCS2). Type D stood out from type C in xenobiotic,
steroid, and tryptophan metabolism with the presence of molecules
such as cytochrome P450 enzyme, UDP-glucuronosyltransferase
(UGT), multidrug resistance 1 (MDR1), aryl hydrocarbon receptor
(AHR), and glutathione-S-transferase (GST). In the type D groups, a
strong correlation existed between transcriptome and proteome for
bothglyconeogenesis(r=0.676,P,0.05)andxenobioticmetabolism
(r=0.683, P,0.05). Type C and D were further represented by
processes involved in blood coagulation and complement cascades,
one of the main functions of the adult liver. Factors involved in
intrinsic blood coagulation and classical complement cascades were
clustered in type C, while those involved in the extrinsic blood
coagulation and lectin and alternate complement cascades coagu-
lation were classified as type D (Figure 2B). Both types shared genes
involved in downstream pathways. With regard to hepatic system
development, the type C group was rich in factors involved in liver
proliferation and regeneration (ACOX1, PTGS1, and SAT). Type
D factors participated in liver proliferation and size control of
hepatocytes (TF, C5, and AHR).
At the proteomiclevel, factors involved inaminoacid metabolism
were abundant in the type C group, and protein levels were highly
correlated with corresponding mRNA levels (r=0.759, P=0.0005).
Likewise, a good correlation was present between proteomics and
transcriptomics data for type C factors involved in carbohydrate
metabolism (r=0.49, P=0.028) and HMGCS2 (r=0.995,
P=0.005), the rate-limiting enzyme for ketogenesis. A correlation
between proteomic and transcriptomic data was also present for
type D factors involved in amino acid metabolism and energy
metabolism (r=0.45 and 0.429, respectively, P,0.01).
E14.5-E15.5 is a key time point in liver development
signaling the loss of hematopoiesis
The cluster analysis unexpectedly revealed that, at both a
proteomic and transcriptomic level, highly significant differences
existed between E14.5 and E15.5 compared to differences between
E11.5 and E14.5 (Figure 3). This strongly suggests that E14.5 to
E15.5 is a key time for liver development, with major changes
occurring in mRNA and protein constituents and thus, the overall
physiological processes. To gain better insight into the changes
during this 24-h period, we focused on the mRNAs that changed
by more than 2 fold and the proteins that changed by more than
1.5 fold. It is interesting that only 8% of these genes were shared
by E11.5-E14.5 and E14.5-E15.5, pointing to differences in the
developmental program at these times. PANTHER and IPA were
applied in further functional analysis.
Suppression of hematopoiesis was associated with down-
regulation of factors such as GATA4, VEGFC, SMARCA4,
CDK6, and MYC. It was also associated with up-regulation of
factors such as LCN2, DDIT3, and RNASEL, which would be
expected to enhance hematopoietic cell apoptosis. Similar changes
occurred at the proteomic level (i.e., the hematopoiesis-associated
proteins, NPM1, EEF2 decreased). At the same time, the
migration of hematopoietic cells would be reduced by the
increased expression of a number of migration inhibitors in the
type C group. Of the total 117 up-regulated network-eligible
genes, 48 participate in blood coagulation and cell movement in
hematological system development and function. The expression
of both proteases and protease inhibitors, including many serine
proteases and serine protease inhibitors, was increased (Figure 4).
This was one of the changes signaling that the newly developed
liver was fully competent to fulfill its functions.
The major biological processes of the adult liver (i.e., immunity
and defense, metabolism of materials) were increased, as reflected
Figure 3. Cluster analysis showing mRNA and protein abun-
dance for genes differentially expressed in mouse liver at
E11.5, E14.5, E15.5, and 3 dpp. All the 2,593 differentially expressed
mRNAs (left panel) and 187 differentially expressed proteins (right
panel) changed more than 2-fold between any two developmental
stages, as analyzed by Cluster 3.0 and TreeView. The expression level of
each mRNA or protein at a development stage is shown relative to its
median abundance across all the developmental stages and is depicted
according to the color scale. Red and green indicate expression levels
above and below the median, respectively. The magnitude of deviation
from the median is indicated by color saturation.
doi:10.1371/journal.pone.0007641.g003
A Switch to Liver Maturation
PLoS ONE | www.plosone.org 5 October 2009 | Volume 4 | Issue 10 | e7641by changes in both the transcriptome and proteome. Various
transferases, oxidoreductases, and lyases were significantly up-
regulated, indicating an increase in the metabolism of lipids,
carbohydrates, proteins, and amino acids as well as the transport
of electrons, lipids, and fatty acids. The main xenobiotic metabolic
pathways, including those involving nuclear factor E2-related
factor 2 (Nrf2), constitutive androstane receptor (CAR), pregnane
X receptor (PXR), and aryl hydrocarbon receptor (AHR), were
up-regulated with the increased expression of the enzymes UGT,
GST, FMO, ALDH, and CYPs. Proteins that are known to
participate in liver development, including C3, C5, and IGFBP-1,
were up-regulated. MYC, CCND1, and GH1 were down-
regulated, controlling the size and proliferation of the liver.
E11.5 to E14.5 is the hematopoietic expansion phase and
is associated with depression of some liver functions
As already mentioned, analysis of dynamic maps revealed that,
during E11.5 to E14.5, genes involved in FL hematopoiesis and
hepatogenesis were differentially regulated. To confirm whether
these were significant events, we focused on genes undergoing at
least a 2-fold change in expression and proteins undergoing a 1.5-
fold change. Geness involved in hematopoiesis or proliferation of
hematopoietic cells, particularly those required for maintaining
HSCs self-renewal, were increased in parallel with increased
expression of activators of ITGA4, RUNX1T1, CCR2, CD24 and
CXCL3 and with decreased expression of suppressors of TGF-b1,
SMO, ID1, ID2, PRTN3 and E2A, and THPO. It was apparent
that the decreased HSC generation triggered by C-MYC was
important to maintain a homeostatic balance between hemato-
poiesis and hepatogenesis. Accordingly, markers of erythropoiesis,
hemoglobin alpha and beta, and uroporphyrinogen decarboxylase
were up-regulated. KITLG and ITGA4, putative regulators of
HSCs motility, increased significantly.
Striking decreases occurred in glycosyltransferases, carbohydrate
kinases, actin-binding cytoskeletal proteins, ribosomal proteins, and
translation factors. This suggests that, from E11.5 to E14.5,
carbohydrate and amino acid metabolism, protein biosynthesis,
general vesicle transport, cell structure changes, cell motility, DNA
repair, and DNA replication were considerably suppressed. CPT1A
(carnitine palmitoyltransferase 1a), a liver-specific gene that is the
rate-limiting enzyme for the fatty acid oxidation pathway, was
down-regulated 2.5 fold. Some forms of lipid metabolism, steroid
metabolism, and lipid and fatty acid transport were elevated;
however, fatty acid metabolism was inhibited.
Figure 4. Up-regulation of blood coagulation and complement cascades at E14.5-E15.5. Genes that were related to blood coagulation
and complement cascades and exhibited 2-fold up-regulation between E14.5 and E15.5 were filtered and integrated into a network using Ingenuity
Pathway Analysis (www.ingenuity.com). Genes related to blood coagulation and complement cascades are tethered to the label with green lines. The
saturation of red shading indicates the degree of up-regulation.
doi:10.1371/journal.pone.0007641.g004
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blot and RT-PCR
Changes in molecules associated with hematopoiesis, HSC
motility, liver development, and TGF-b signaling were confirmed
by western blot and RT-PCR (Figures 5–6). For all factors, the
results were consistent with observations obtained through
proteomic or transcriptomic approaches. Type A factors associ-
ated with FL hematopoiesis-related factors (such as AFP, TRAP1,
NPM1, eEF2, CA2, 14-3-3E, BCL2L1, RUNX1, and
SMARCA5) increased to E14.5 and decreased thereafter as seen
by western blot and RT-PCR (Figures 5–6). KRAB-ZFPs, ZFX,
KLF6, and PRDM16 as well as their specific KRAB-binding
protein, KAP1 (KRAB-Associated Protein 1)[24] were expressed
in the same manner (Figure 5). To determine if the putative
molecules controlling cell movement in BM may also function in
the movement of FL hematopoietic cells, we analyzed CXCL12,
JAG1, and CDH2 expression (Figure 5). In contrast to KITL,
COF1, LAMR1, ADRB2, and ITGA4 (Figures 5–6), these
proteins did not change during FL hematopoiesis.
Type C-like expression profiles of other important enzymes and
proteins participating in liver metabolism were also validated by
western blot and RT-PCR (Figures 5–6). These included ACOX1,
SAT, PTGS1, HEXB, KHK, HMGCS2, STARD5, and the
related transcription factors PPARA, FOXA3 (HNF3G), FOXA1
(HNF3B), and HNF4A. Finally, validations were performed for
TGF-b and SMAD4 (Figures 5–6), TGF-b signaling pathway
components that, aside from acting as inhibitors of hematopoiesis,
also inhibit hepatocyte proliferation during the development of
late fetal to postnatal liver[3].
Discussion
FL-HSCs undergo a high frequency of cycling and self-renewal
until E14.5, contrasting sharply to the quiescent and limited self-
renewal of BM-HSCs[4].This suggests that the FL provides a
microenvironment that is more conducive to supporting HSCs.
For this reason, FL is considered a good model to study the
molecular partners governing the self-renewal and proliferation of
HSCs. In this report, we describe, for the first time, a global view
of the development of FL hematopoiesis at the molecular level.
Genes fluctuating strictly in accord with the development of FL
hematopoiesis (type A) were primarily involved in hematopoietic
expansion and were FL-HSC specific. Hepatic progenitors
probably contributed to the development of FL hematopoiesis,
with some pathways being restrained, especially metabolic
pathways producing reactive oxygen species (ROS).
Compelling evidence supports the idea that intrinsic and
extrinsic cellular mechanisms synergistically limit the expansion
and differentiation of stem cells, especially HSCs[25]. Here,
integration of transcriptomic and proteomic data identified
transcription factors that fluctuated during FL hematopoiesis (type
A) and were knitted into an interaction network (Figure 2A). Some
of these transcription factors are known to control the self-renewal
of HSCs or hematopoietic commitment of ESCs. BCL2L1,
NPM1, SMARCA5, EZH2, KITLG, and CREBBP (CREB-
binding protein) contribute to the formation, self-renewal, long-
term survival, or complete long-term repopulating potential of the
hematopoietic stem cell population[18–22]. As the central
‘‘nodes’’ in the network (Figure 2A), these factors control the
expression of other partners, as reflected in both the proteome and
transcriptome. GATA1 and BCL2L1, which exhibit a type A
pattern of transcription, interact with the type A proteins HBA2
and TPT1, respectively[26]. At E11.5-E14.5, the hematopoiesis
inhibitors were significantly suppressed. These included TGF-b
Figure 5. Validation of proteomic changes by western blot. Expression of select proteins in the mouse liver at E11.5, E14.5, E15.5, and 3 dpp.
Proteins that were analyzed included those exhibiting a type A pattern of expression (left column), those related to the mobilization of hematopoietic
stem cells (middle column), and those related to liver function or other functions (right column). GAPDH served as an internal control.
doi:10.1371/journal.pone.0007641.g005
Figure 6. Validation of transcriptomic changes by RT-PCR. The
mRNA expression of select mouse liver genes at E11.5, E14.5, E15.5, and
3 dpp. Genes that were analyzed included genes related to
hematopoiesis (left column) and genes related to liver function and
development (right column). GAPDH served as an internal control.
doi:10.1371/journal.pone.0007641.g006
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a Hedgehog signaling protein (SMO), and IDs (DNA-binding
protein inhibitor, ID) (ID1 and ID2) [27–29]. It is important to
note that this protein profile is probably distinctive for FL
hematopoiesis, as suggested by a comparison of FL-HSC- and LT-
HSC-BM-specific genes (Figure S3), and many type A genes were
newly identified as important for hematopoiesis or as having no
clear functional annotation. The results relating to type A factors,
as well as other dynamic types, demonstrate that the experimental
approaches we used were successful for characterizing the features
of FL hematopoiesis and other type-specific biological functions.
Many type A transcription factors identified here had unknown
functions. Half of these were hematopoietic tissues-enriched and
over half were KRAB-ZNFs, agreeing well with proteomic data
obtained in human FL at the hematopoietic peak[23]. In recent
years, more and more KRAB-ZNFs have been shown to be
influential to hematopoiesis regulation. Among the KRAB-ZNFs
identified here, ZFX, KLF6, and PRDM16 are already known to
be important hematopoietic regulators. For instance, ZFX
regulates the self-renewal of ESCs and HSCs[30]. We found that
KAP1, a specific, high-affinity KRAB-binding protein[24], had an
expression pattern similar to that of KRAB-ZFPs, inferring that
KAP1 may assist KRAB-ZFPs in promoting FL hematopoiesis
(Figure 5). Taken together, these results also suggest that the
transcription factors mentioned control the self-renewal and
proliferation of HSCs.
If transcriptional regulation is an intrinsic element governing FL
hematopoiesis, then the FL hematopoietic microenvironment is an
extrinsic one. Given their direct spatial relationship with
hematopoietic cells, hepatic progenitors are the most likely cell
type that assembles the FL hematopoietic microenvironment in
concert with other stromal cell populations. Hepatic cells or
nonhematopoietic cells isolated from FL at E14.5 or E15 support
proliferation of hematopoietic progenitors from FL and adult BM
in co-culture; however, this is not the case with cells obtained at
E18.5[10,31]. Obviously, hepatic cells at the hematopoietic
expansion phase are very different from those at the hematopoietic
shrinking phase.
Our data revealed that liver functions were partially repressed
during the FL hematopoietic expansion phase (from E11.5 to
E14.5) but were significantly increased thereafter (at E15.5, type C
genes). These liver functions included metabolism of lipids,
carbohydrates, and amino acids, in particular catabolism/
utilization of materials and energy production processes such as
fatty acid beta-oxidation, ketogenesis, and degradation of
carbohydrates and amino acids. Other liver functions were also
increased, as seen by up-regulation of factors involved in classical
complement cascades and intrinsic coagulation pathways. An
example of a change associated with increased metabolic liver
functions at E15.5 is up-regulation of HEXB, which hydrolyzes
terminal non-reducing N-acetyl-D-hexosamine residues into N-
acetyl-beta-D-hexosaminides. We also observed an up-regulation
of KHK (ketohexokinase or fructokinase), which initiates the
intracellular catabolism of a large proportion of dietary carbohy-
drates, as well as an up-regulation of STARD5, a cholesterol-
binding protein that does not have well-understood functions but is
thought to be important for cholesterol metabolism and
maintenance of cellular homeostasis[32].
Surprisingly, liver functions emerging at E15.5 included not only
those functions that were suppressed during hematopoietic
expansion, but also functions that continued to increase throughout
liver development. These functions included biotransformation,
steroid and tryptophan metabolism, extrinsic blood coagulation,
and the lectin pathway of complement cascades. This intimates that
the development of the FL is delayed with undifferentiated hepatic
progenitors during the FL hematopoietic expansion phase and then
enters a full-scale maturation stage as soon as FL hematopoiesis
begins receding. The delay in liver development is probably
required for FL hematopoiesis, as evidenced by the co-culture of
primitive hepatocytes with HSCs. FL stromal cell populations at
E12.5to E14.5withepithelial-to-mesenchymal transition features(a
characteristic of hepatoblasts) have hematopoietic supportive
capacity only before oncostatin M-induced hepatocytic differenti-
ation[33]. Moreover, Dlk, a specific marker of hepatic progenitors,
seems to regulate the hematopoietic-supporting capacity of liver
stromal cells[34]. Therefore, hepatic progenitors are an important
component of the FL microenvironment at this time point. Indeed,
liver parenchyma is enriched in hepatoblasts during the expansion
period of FL hematopoiesis. E14 rat liver possesses a higher
proportion of hepatoblasts than the E18 liver[35]. Mouse FL also
expresseshigherlevelsofDlk1duringE12.5-E16.5than during later
phases[36]. Type C genes probably reflect the remarkable nature of
hepatic progenitors in the FL.
Multiple mechanisms may account for the ability of hepatic cells
to contribute to the FL hematopoietic microenvironment during
the hematopoietic expansion phase. First, hepatic cell-derived
cytokines that negatively regulate hematopoiesis seem to be limited
when FL-HSCs are expanding. Liver is the primary organ of
thrombopoietin production, and hepatocyte is consider to be the
only producer of this cytokine in fetal liver[37]. Thrombopoietin/
MPL (thrombopoietin receptor) signaling is crucial for maintaining
HSC quiescence in the postnatal hematopoietic niche, and
decreases in thrombopoietin do not inhibit development of fetal
HSCs in thrombopioetin knockout mice[38]. The 2.8-fold
decrease in thrombopoietin (a type C factor) observed during
E11.5-E14.5 suggests that the temporal decrease in thrombopoi-
etin in hepatocytes is required to support the long-term self
renewal and proliferation of HSCs during the expansion phase of
FL hematopoiesis. An extra benefit is that decreased thrombo-
poietin reduces ROS generation[39]. Second, we found some
ROS generation pathways in fetal liver are limited to FL
hematopoiesis. A hypoxic milieu is essential for the survival of
HSCs and stromal cells and provides long-term protection from
oxidative stress, as occurs in FL hematopoiesis[40]. A hypoxic
microenvironment contributes to increases in the hematopoietic
regulators mentioned above, such as CREBBP1, NPM1, KITLG,
and BCL2L1[41–42]. Amazingly, we found that some rate-
limiting enzymes in ROS generation pathways were down-
regulated during the expansion phase of FL hematopoiesis and
then up-regulated as FL hematopoiesis began to come to an end
(type C factors). Among those factors, changes in three ROS-
producing factors (ACOX, PTGS1, and SAT) were further
confirmed at the mRNA or protein level (Figures 5–6). ACOX1
(acyl-coenzyme A oxidase) is the rate-limiting enzyme for the
peroxisomal very-long-chain fatty acid beta-oxidation pathway,
which controls the generation of hydrogen peroxide. Overexpres-
sion or deficiency of ACOX1 will increase ROS and hepatocyte
proliferation[43]. PTGS1 (prostaglandin-endoperoxide synthase),
also known as COX-1 (cyclooxygenase-1), is the rate-limiting
enzyme for the pathway that catalyzes the regio- and stereo-
specific oxygenation of polyunsaturated fatty acids to produce
prostaglandin, thromboxane, and hydroperoxide products. Inhi-
bition of PTGS1 alone tends to delay liver regeneration[44]. SAT
(spermidine/spermine N1-acetyltransferase) is the only rate-
limiting enzyme for polyamine degradation, which generates
hydrogen peroxide as a byproduct. Increased SAT levels deplete
hepatic polyamine levels, making these levels insufficient for
initiation of early liver regeneration[45]. Thus, all three of these
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proliferation through ROS production.
The changes of those ROS pathways or other metabolic
pathways might be ascribed to liver-enriched transcription factors.
HNF4a (hepatocyte nuclear factor 4 alpha) and FOXA3 are two
of the most important regulators of hepatogenesis and potential
transcriptional controllers of metabolism-associated genes[46–48].
HNF4a, a repressor the vital enzymes of ROS pathways
mentioned, decreased between E11.5 and E14.5, while it increased
at E15.5. HNF4a might negatively regulate the expression of
CPT1A (2.5-fold decrease from E11.5 to E14.5), HMGCS2, and
ACOX1 as well as control hydrogen peroxide production in
peroxisomal oxidation[47–48]. However, the exact mechanisms
regulating these changes during FL hematopoiesis are unknown.
The up-regulation of xenobiotic metabolizing enzymes and
antioxidant enzymes that was observed between E11.5 and E14.5
was probablyrelated to the suppression of the genes mentioned above
as well as their key transcription factor, PPARA (Figure 5). PPARA is
not indispensable for transcriptional regulation of ACOX1; however,
in mice with ACOX1 deficiency or in which peroxisomal fatty acid
beta-oxidation has been disrupted, PPARA and its targeted genes are
up-regulated[43]. Here, when ACOX1 down-regulated during the
expansion phase of FL hematopoiesis, PPARA-regulated proteins
(CYP4s, EHHADH, and FABP) were up-regulated (Table S2).
Overexpression of PPARA elevates the activity of the antioxidant
enzymes catalase and SOD[49]. We also found that protein levels of
the antioxidant enzymes catalase, SOD, PRDX1, PRDX2, and
glutathione transferases were up-regulated (Table S2).
Taken together, our results reveal that, during the hemato-
poietic expansion phase, the FL seems to have a full complement
of hepatic progenitors, though only a limited development of
liver functions occurs. This is especially true of those depressed
functions, which are attributed to building hematopoietic
microenvironment, such as the ROS-producing pathways.
However, as soon as hematopoies i sb e g i n st of a d ea tE 1 4 . 5 -
E15.5, all of FL functions are wholly promoted. In conclusion,
under the selective pressure, liver development is partially
limited to support hematopoiesis. And the removal of hemato-
poiesis opens the door of liver maturation. Thus, our research
globally evidences that the shift of hematopoiesis at E14.5-E15.5
is a key time point at which the primary development of the FL
shifts to a maturation stage. How these features of FL
development are shaped by intrinsic machinery or hematopoi-
etic stress is currently unknown and awaits further investigation.
Supporting Information
Figure S1 The differentially expressed protein spots displayed by
merged the gels of mice livers of E14.5 and 3 dpp. Green spots are
highly expressed in E14.5, red ones are highly expressed in 3 dpp liver,
and the white ones are expressed in the equal abundance in the both.
Found at: doi:10.1371/journal.pone.0007641.s001 (1.80 MB EPS)
Figure S2 Hierarchical clustering of biological functions and
four dynamic types based on protein expression data. The
biological functions are annotated by PANTHER. The ratio level
of each function in a type is relative to its median ratio across all
the four types and is depicted according to a color scale shown at
the bottom. Red and green indicate the ratio of each function of a
type respectively above and below the median. The magnitude of
deviation from the median is represented by the color saturation.
Found at: doi:10.1371/journal.pone.0007641.s002 (2.32 MB EPS)
Figure S3 Comparison of the genes of type A with the mouse
FL-HSCs specific, LT-HSC-adult (BM) specific genes from the
Stem Cell Database (SCDb) constructed by Phillips R.L. et al [24].
The X-axis was the different biological functions, and the Y-axis
was the ratio of the genes of each function to the total gene of the
three compared gene groups (type A of our data, the mouse FL-
HSCs specific, LT-HSC-adult (BM) specific genes).
Found at: doi:10.1371/journal.pone.0007641.s003 (0.64 MB EPS)
Figure S4 Protein ubiquitination pathways in type A and B
identified by Ingenuity Pathway Analysis (www.ingenuity.com).
The red labeled nodes were from type A, and the green ones from
type B, and the half red and green ones were shared by both types.
Found at: doi:10.1371/journal.pone.0007641.s004 (1.98 MB EPS)
Figure S5 Comparison between the transcriptomes and pro-
teomes. (A) The tissue-specific or -enriched expression profile of the
proteins with or without significant relationship to their mRNA.
Mouse gene expression information of embryonic tissues including
blastocysts and embryonic tissues at E6.5-E10.5, and hematopoietic
tissues including bone marrow, thymus, spleen, lymphoid and
lymph cells were referenced from GeneAtlas (http://symatlas.gnf.
org/SymAtlas/) annotation. (B) The correlation between transcrip-
tome and proteome for individual biological function.
Found at: doi:10.1371/journal.pone.0007641.s005 (1.24 MB EPS)
Supplemental Materials S1 Materials and methods; Compar-
ison of quantitative liver transcriptomes and proteomes;Recession
of the early embryonic development genes - type B.
Found at: doi:10.1371/journal.pone.0007641.s006 (0.09 MB
PDF)
Table S1 Differentially expressed protein spots for mouse livers
of the four different developmental stages
Found at: doi:10.1371/journal.pone.0007641.s007 (0.03 MB
DOC)
Table S2 Proteome data
Found at: doi:10.1371/journal.pone.0007641.s008 (0.41 MB
XLS)
Table S3 Transcriptome data
Found at: doi:10.1371/journal.pone.0007641.s009 (1.46 MB
XLS)
Table S4 Components of protein-ubiquitination pathway
emerged in type A and B
Found at: doi:10.1371/journal.pone.0007641.s010 (0.03 MB
DOC)
Table S5 Experimental design of DIGE. Mice livers of three
stages, E11.5, E14.5, E15.5 and 3 dpp, For each sample pair,
triplicate gels were run, which are represented by number 1, 2
and 3.
Found at: doi:10.1371/journal.pone.0007641.s011 (0.03 MB
DOC)
Table S6 PCR Primers and PCR Conditions
Found at: doi:10.1371/journal.pone.0007641.s012 (0.06 MB
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